Author

Biotech Connection Singapore 85 posts 0 comments

Biotech Connection Singapore (BCS) is part of an international network of non-profit organizations, that aims to promote the transfer of ideas from theory to real world applications by providing a platform for fostering interaction between academia, industry and businesses.

Communications

Scientific and Technological Advancements in Diabetes Management

By Low Su Jun Blaise and Lim Chang Siang Diabetes mellitus is a disease caused by the body’s inability to regulate blood sugar (glucose) levels, resulting in persistently high glucose levels in the body. This condition occurs when the body is unable to produce sufficient insulin – a hormone secreted by the pancreas to promote uptake of glucose from the blood into various cells to generate energy for bodily functions – or respond appropriately to insulin. There are 4 types of diabetes: Type 1 diabetes, Type 2 diabetes, monogenic diabetes and gestational diabetes. Type 1 diabetes results from the destruction of insulin-producing cells in the pancreas, which causes a lack of insulin secretion. Type 1 diabetes patients require administration of insulin injections to manage the disease . Type 2 diabetes results from the inability of various cells in the body to respond appropriately to insulin, which eventually impairs insulin secretion. Patients with Type 2 diabetes typically require…
Events

What Can You Do with a PhD In Biomedical Field?

Thursday, October 10, 2019 6:00 PM – 9:00 PM Tan Chin Tuan Lecture Theatre, 50 Nanyang Ave, NTU Singapore 639798 For the first time, Biotech Connection Singapore (BCS) has partnered with NTU Graduate Student Association (NTUGSA) to hold an on-campus career experience sharing event on 10th Oct 2019. This event was supported by the NTU Student Affairs Office and Career & Attachment Office (CAO). The aim of this event was to introduce NTU biomedical graduate students to a variety of career options available outside of academia and encourage them to take control of their professional life. This event featured five biomedical and science PhD holders representing different industries to share their experience in transitioning into non-academic careers and each gave their insights on how to tackle some common challenges during such transitions. The Tan Chin Tuan Lecture theatre was filled with 100+ graduate students, mainly from…
Communications

Medical writing and the healthcare industry

by Zheng Shan CHONG Mention medical writing to most people and you’ll be met with confused and curious looks. ‘Does that mean writing about health issues in the newspapers?’ someone once asked me. This response isn’t surprising considering the largely behind-the-scenes role that medical writers play in the healthcare industry. Yet, the global medical writing market size has been valued at USD 1.72 billion in 2018 and is expected to grow 10.3% from 2019 to 2026, with the highest growth predicted to be in the Asia-Pacific region . The reason for this growth? Increased outsourcing by pharmaceutical and biotechnology companies as well as tighter regulations by authorities, especially over transparent clinical trial reporting. Economic pressure from expiring patents and the high attrition rates of candidate compounds have already led to big pharmaceutical firms scaling down their workforces in order to increase R&D efficiency . This in turn has led to a concomitant increase in…
Events

AI in Healthcare

FThere has been a rapid expansion in AI-based technologies in recent years, including its application in the healthcare space. In this event, we have featured innovators who are using AI-based technologies to improve clinical outcomes, as well as those well-versed in IP protection of such technologies. A huge audience joined us for an evening of short talks and what will be an enlightening discussion on how entrepreneurs, technologists, clinicians and IP experts can come together to drive improvements in healthcare.
Events

IGNite: A Fireside Chat with Mr. Ng Choon-Peng, CEO & Co-founder of immunoSCAPE

Fireside chat with Mr. Ng Choon-Peng, CEO and Co-founder of immunoSCAPE, which provides immune profiling services to drug development companies and research groups focused on developing immunotherapy for cancer, infectious diseases, and autoimmune diseases. The fireside chat was moderated by Ms. Doralyn Chan (Manager, Funding, Entrepreneur First Asia). IGNite, short for Innovators Gathering Night, is a series of fireside chats with biotech and medtech innovators to find out what ignites their passion to innovate within their fields. It also provides a platform for current and future innovators to meet and network, and ignite conversations leading to collaborative opportunities. The fireside chat is informal and casual, and participation/questions from the audience are greatly encouraged.